Sukdeb Mondal

813 citations
9 papers · 646 indexed · h-index 8
Topics
Carcinogens and Genotoxicity Assessment (2 papers)Cancer-related Molecular Pathways (2 papers)Pluripotent Stem Cells Research (1 paper)
Partner nations
United StatesSpain

In The Last Decade

Sukdeb Mondal

9 papers receiving 557 citations

Peers

Sukdeb Mondal
Comparison fields: 5 of 84
  • Molecular Biology 394
  • Cancer Research 262
  • Oncology 139
  • Genetics 86
  • Health, Toxicology and Mutagenesis 60
Replace Michael F. Callaham with:
Michael F. Callaham United States
I. G. Walker Canada
S.W. Dean United Kingdom
Henriette Brésil France
Yoshisuke Nishi Japan
Colette J. Rudd United States
Andrew R. Kraynak United States
Miroslava Protić‐Sabljić United States
Libby R. Friedman United States
David A. Scicchitano United States
Sukdeb Mondal relative to Michael F. Callaham United States Michael F. Callaham's profile →
Citations per field
00.5×1.5×2.1×
Michael F. Callaham · 1×
Citations per year

Countries citing papers authored by Sukdeb Mondal

Since Specialization
Citations

This map shows the geographic impact of Sukdeb Mondal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sukdeb Mondal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sukdeb Mondal more than expected).

Fields of papers citing papers by Sukdeb Mondal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sukdeb Mondal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sukdeb Mondal. The network helps show where Sukdeb Mondal may publish in the future.

Co-authorship network of co-authors of Sukdeb Mondal

This figure shows the co-authorship network connecting the top 25 collaborators of Sukdeb Mondal. A scholar is included among the top collaborators of Sukdeb Mondal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sukdeb Mondal. Sukdeb Mondal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1
Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters.
25
2 1
3
Enhancement of X-ray transformation by 12-O-tetradecanoyl-phorbol-13-acetate in a cloned line of C3H mouse embryo cells.
86
4 10
5
Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides.
56
6 127
7
Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells.
242
8 20
9 79

About Sukdeb Mondal

Sukdeb Mondal is a scholar working on Geriatrics and Gerontology, Cancer Research and Biotechnology, having authored 9 papers that have together received 646 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (2 papers), Cancer-related Molecular Pathways (2 papers) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Cancer Research (262 citations), Molecular Biology (394 citations) and Oncology (139 citations). Sukdeb Mondal has collaborated with scholars based in United States and Spain. Frequent co-authors include Charles Heidelberger, David Brankow, Ann R. Kennedy, John B. Little, Ulf R. Rapp, Peter A. Jones, William F. Benedict, Mary S. Baker, M. J. Embleton and Hans Marquardt. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026